newsTinostamustine has been granted Orphan Drug Designation by the European…
5 August 2020 | By Victoria Rees (European Pharmaceutical Review)
Tinostamustine has been granted Orphan Drug Designation by the European Commission to the treatment of T-cell prolymphocytic leukaemia (T-PLL).